AKT1 and ovarian carcinoma: Moreover, EA prevented the phosphorylation of S6K1 and 4EBP, downstream targets of mTORC1 as well as Akt, indicating that inhibition of the Akt/mTOR pathway can also play a role in the antiproliferative effect of EA in ovarian cancer cells.